Cancers | Editor’s Choice Articles from 2022 to 2023 Related to Tumor Microenvironment
Editor's Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the Editor's Choice Articles related to tumor microenvironment, a curated list of high-quality articles from 2022 to 2023 Cancers (ISSN: 2072-6694). The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/cancers/editors_choice.
The list of relevant papers can be seen below:
“Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy”
by Leah Davis, Matthias Recktenwald, Evan Hutt, Schuyler Fuller, Madison Briggs, Arnav Goel and Nichole Daringer
Cancers 2022, 14(5), 1259; https://doi.org/10.3390/cancers14051259
Available online: https://www.mdpi.com/2072-6694/14/5/1259
“Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer”
by Tomohiko Shinkawa, Kenoki Ohuchida and Masafumi Nakamura
Cancers 2022, 14(16), 3994; https://doi.org/10.3390/cancers14163994
Available online: https://www.mdpi.com/2072-6694/14/16/3994
“Tumor Microenvironment as a Therapeutic Target in Melanoma Treatment”
by Naji Kharouf, Thomas W. Flanagan, Sofie-Yasmin Hassan, Hosam Shalaby, Marla Khabaz, Sarah-Lilly Hassan, Mosaad Megahed, Youssef Haikel, Simeon Santourlidis and Mohamed Hassan
Cancers 2023, 15(12), 3147; https://doi.org/10.3390/cancers15123147
Available online: https://www.mdpi.com/2072-6694/15/12/3147
“Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy”
by Alison K. Buxton, Salma Abbasova, Charlotte L. Bevan and Damien A. Leach
Cancers 2022, 14(24), 6189; https://doi.org/10.3390/cancers14246189
Available online: https://www.mdpi.com/2072-6694/14/24/6189
“PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies”
by Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, Maria Carmela Di Marcantonio, Mariagrazia Piscione, Raffaella Muraro and Gabriella Mincione
Cancers 2023, 15(11), 2923; https://doi.org/10.3390/cancers15112923
Available online: https://www.mdpi.com/2072-6694/15/11/2923
“Molecular Systems Architecture of Interactome in the Acute Myeloid Leukemia Microenvironment”
by V. A. Shiva Ayyadurai, Prabhakar Deonikar, Kevin G. McLure and Kathleen M. Sakamoto
Cancers 2022, 14(3), 756; https://doi.org/10.3390/cancers14030756
Available online: https://www.mdpi.com/2072-6694/14/3/756
“Onco-miR-21 Promotes Stat3-Dependent Gastric Cancer Progression”
by Janson Tse, Thomas Pierce, Annalisa L. E. Carli, Mariah G. Alorro, Stefan Thiem, Eric G. Marcusson, Matthias Ernst and Michael Buchert
Cancers 2022, 14(2), 264; https://doi.org/10.3390/cancers14020264
Available online: https://www.mdpi.com/2072-6694/14/2/264
“STAT3 Signaling in Breast Cancer: Multicellular Actions and Therapeutic Potential”
by Sarah Q. To, Rhynelle S. Dmello, Anna K. Richards, Matthias Ernst and Ashwini L. Chand
Cancers 2022, 14(2), 429; https://doi.org/10.3390/cancers14020429
Available online: https://www.mdpi.com/2072-6694/14/2/429
“AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis”
by Marie-Anne Goyette and Jean-François Côté
Cancers 2022, 14(3), 466; https://doi.org/10.3390/cancers14030466
Available online: https://www.mdpi.com/2072-6694/14/3/466
“Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets”
by Ralf-Peter Czekay, Dong-Joo Cheon, Rohan Samarakoon, Stacie M. Kutz and Paul J. Higgins
Cancers 2022, 14(5), 1231; https://doi.org/10.3390/cancers14051231
Available online: https://www.mdpi.com/2072-6694/14/5/1231
“Impact of Lipid Metabolism on Antitumor Immune Response”
by Nesrine Mabrouk, Baptiste Lecoeur, Ali Bettaieb, Catherine Paul and Frédérique Végran
Cancers 2022, 14(7), 1850; https://doi.org/10.3390/cancers14071850
Available online: https://www.mdpi.com/2072-6694/14/7/1850
“Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context”
by Mannon Geindreau, Mélanie Bruchard and Frédérique Vegran
Cancers 2022, 14(10), 2446; https://doi.org/10.3390/cancers14102446
Available online: https://www.mdpi.com/2072-6694/14/10/2446
“The Kynurenine Pathway and Cancer: Why Keep It Simple When You Can Make It Complicated”
by Roumaïssa Gouasmi, Carole Ferraro-Peyret, Stéphane Nancey, Isabelle Coste, Toufic Renno, Cédric Chaveroux, Nicolas Aznar and Stéphane Ansieau
Cancers 2022, 14(11), 2793; https://doi.org/10.3390/cancers14112793
Available online: https://www.mdpi.com/2072-6694/14/11/2793
“The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens”
by Sukrit Mahajan, Mirko H. H. Schmidt and Ulrike Schumann
Cancers 2023, 15(7), 2024; https://doi.org/10.3390/cancers15072024
Available online: https://www.mdpi.com/2072-6694/15/7/2024
“Environmental and Lifestyle Cancer Risk Factors: Shaping Extracellular Vesicle OncomiRs and Paving the Path to Cancer Development”
by Valentina Bollati, Paola Monti, Davide Biganzoli, Giuseppe Marano, Chiara Favero, Simona Iodice, Luca Ferrari, Laura Dioni, Francesca Bianchi, Angela Cecilia Pesatori et al.
Cancers 2023, 15(17), 4317; https://doi.org/10.3390/cancers15174317
Available online: https://www.mdpi.com/2072-6694/15/17/4317
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office